caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1770577025

Kyle Van De GraaffM.D.

PRACTICECORVALLIS CLINIC PCSee all providers at this practice →
DermatologyCorvallis, ORI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Kyle Van De Graaff's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Edward Wolf
Internal Medicine · Corvallis, OR
4897
James Wolfe
Pathology · Louisville, KY
42101
Elizabeth Mcquitty
Pathology · Corvallis, OR
40105
Brian Curtis
Internal Medicine · Corvallis, OR
2249
ATHAY, STEVEN2133
ALBANY GENERAL HOSPITAL2051
Robert Wirth
Internal Medicine · Corvallis, OR
1639
MURPHY, JOHN1319
James Dunn
Diagnostic Radiology · Corvallis, OR
1315
Kent Mercer
Physician Assistant · Corvallis, OR
1235
David Huang
Ophthalmology · Corvallis, OR
1113
Leslie Arpin
Diagnostic Radiology · Corvallis, OR
1112
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,551
Unique beneficiaries
—
Total services
2,439
Distinct HCPCS
16
Medicare payment
$107K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 151 Dermatology providers in OR — above median (cohort median 2,279).
PRESCRIBING · PART D · 2024
Total Rx claims
1,083
Beneficiaries
—
Total drug cost
$242K
Distinct drugs
19
Brand share
16.8%
Top prescribed drugs
Triamcinolone Acetonide178 claims
Clobetasol Propionate168 claims
Methotrexate Sodium138 claims
Ketoconazole134 claims
Fluorouracil124 claims
QUALITY · MIPS · 2024
Final MIPS score
88.2
Quality
84.8
Cost
75.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.55%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.